ALEXANDRIA, Va., June 19 -- The United States Patent and Trademark Office (USPTO) published about the trademark 'OTEZLA XR' in its latest official gazette. The trademark application with the serial number 97504938 was filed on Jul. 15, 2022.
Here are the other related details:
Goods and Services: 5 - pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system; pharmaceutical preparations for the treatment of chronic inflammatory diseases, ankylosing spondylitis, psoriasis, psoriatic arthritis and cancer
International/US Class(es): 5
Mark Drawing Code: 4 - STANDARD CHARACTER MARK
Current Owner(s): Amgen Inc. One Amgen Center Drive Thousand Oaks CA CALIFORNIA 913201799 3 C...